TOKYO – Gilead Sciences Inc., the U.S. pharmaceutical firm that developed remdesivir, priced the antiviral drug at $2,340 dollars, equivalent to more than ¥250,000, per COVID-19 patient for wealthy countries like Japan.
Read More...
For its 70th anniversary celebration, the country’s leading and largest broadcast firm GMA Network, Inc. wholeheartedly offers its own high-quality and affordable Digital Terrestrial Television (DTT) receiver "GMA Affordabox."
Read More...
The Japan International Cooperation Agency and the Department of Finance signed a combined total of 154 billion yen Official Development Assistance for infrastructure projects in Cebu and Davao emphasizing JICA's support to the Philippine economy affected by COVID-19.
Read More...
MANILA/TOKYO – Clinical trials in the Philippines will begin soon for the Japanese antiviral drug Avigan, also known as favipiravir, to determine if it is effective in treating the new coronavirus (COVID-19).
Read More...
TOKYO – The Japanese Health Ministry has released a smartphone application that notifies users if they have been in contact with someone diagnosed with COVID-19 to help combat the spread of the pneumonia-causing virus.
Read More...